Larvol Group, dba Larvol, 548 Market St. Suite 44120, San Francisco, CA 94104 (“Larvol”, “Company”, “we”, “us”, or “our”), may reference the names, trademarks, service marks, logos, trade names, meeting titles, event branding, and other proprietary identifiers of third-party organizations.
Such organizations may include, by way of example, the European Society for Medical Oncology (ESMO), the American Society of Hematology (ASH), the American Society of Clinical Oncology (ASCO), academic institutions, publishers, conference organizers, pharmaceutical companies, and other industry entities.
References to third-party brands may appear throughout Larvol’s Services, including but not limited to the Larvol Web Application (Larvol Omni), the Oncology Biomarker Platform (Larvol Veri), the Oncology Clinical Trial Data Search Platform (Larvol CLIN), the Online Conference Platform (Larvol CONF), the Marketing Intelligence Database (Delta), www.larvol.com, and in associated materials such as reports, dashboards, data visualizations, white papers, presentations, publications, marketing materials, documentation, and customer communications.
Larvol may also reference such organizations, meetings, and brands in connection with conference coverage, scientific analysis, clinical trial reporting, market intelligence, editorial commentary, or real-time analytics related to oncology research and industry developments. These references may appear across Larvol’s digital platforms and social media channels, including but not limited to X (Twitter), LinkedIn, and other professional or informational networks.
All references to third-party names, trademarks, or logos are used solely for descriptive, informational, analytical, comparative, editorial, or reporting purposes, including identifying conferences, organizations, publications, clinical trials, scientific presentations, or related subject matter.
Use of such third-party identifiers by Larvol:
All third-party trademarks, logos, brand names, event names, and related intellectual property referenced within the Services remain the property of their respective owners. Larvol references such identifiers only as reasonably necessary to identify the relevant organization, conference, publication, clinical study, product, or subject matter in a factual and non-misleading manner.
Larvol does not claim ownership of such third-party content and provides attribution where reasonably available or appropriate.
Nothing contained within Larvol’s Services or materials should be interpreted as suggesting ownership of, rights in, or authorization to use any third-party intellectual property beyond such limited descriptive or nominative reference.
Such references are used for informational, analytical, or reporting purposes only. The views or statements expressed in third-party content belong solely to the respective authors and do not necessarily reflect the views of Larvol.
Larvol may reference, quote, summarize, or analyze publicly available third-party content, including conference commentary, scientific discussions, or posts shared by clinicians, researchers, organizations, or institutions on social media platforms.
Larvol provides independent analysis, commentary, and reporting related to scientific meetings, medical conferences, and research events. Unless explicitly stated otherwise, Larvol is not affiliated with, sponsored by, endorsed by, or acting as an official partner of any conference organizer, professional society, or event referenced in its materials.
Any conference-related content produced by Larvol represents independent analysis and interpretation of publicly available information, conference presentations, scientific publications, and related discussions.
